##  [Generic Drug Registration Philippines: Process, Requirements, and Timelines](/blog/generic-drug-registration-philippines-process-requirements-and-timelines) 

    May 20, 2026 

  ![Generic Drug Registration Philippines: Process, Requirements, and Timelines]()

2 min read 

- [Medicinal Products](/blog-main-categories/medicinal-products)
- [Regulatory Affairs](/blog-main-categories/regulatory-affairs)





 

Entering the Philippine pharmaceutical market requires a clear understanding of the Philippines drug registration process, documentation standards, and applicable approval pathways. A structured approach to the generic drug registration Philippines process helps companies ensure compliance, avoid delays, and achieve faster market access while meeting evolving FDA Philippines requirements.

## Responsible Agency

- [Food and Drug Administration (FDA) Philippines](https://www.freyrsolutions.com/what-is-the-fda-philippines), specifically, the Center for Drug Regulation and Research (CDRR) is responsible for the entire Philippines drug registration process.

### Main Steps in the Generic Drug Registration Process

| **Step** | **Activity** | **Details** |
|---|---|---|
| 1 | Obtain License to Operate (LTO) | Only companies with a valid FDA License to Operate may apply. |
| 2 | Prepare Dossier/Requirements | Use the ASEAN Common Technical Dossier (ACTD) format, as required by AO No. 2013-0021 and [AO No. 2024-0013](https://www.fda.gov.ph/administrative-order-no-2024-0013-general-rules-and-regulations-pharmaceutical-products-and-ingredients-intended-for-human-use-on-the-registration-of-active-pharmaceutical/); checklist published on FDA website. Preparing a compliant ACTD dossier Philippines is critical for successful evaluation and approval. |
| 3 | Online Application | Submission is via the FDA eServices Portal ([https://eservices.fda.gov.ph](https://eservices.fda.gov.ph/)). You select “Drug” and classification (e.g., generic prescription). |
| 4 | Pre-assessment | FDA checks completion of documents; incomplete applications are not accepted. |
| 5 | Order of Payment | Issued after document completeness is confirmed. |
| 6 | Evaluation | Technical review of dossier—may include full, abridged, or verification/reliance pathway reviews. |
| 7 | Decision Issuance | If approved, Certificate of Product Registration (CPR) is issued. If rejected, a deficiency notice or disapproval is given. |

## Documentary Requirements (for Initial Registration)

- Administrative data: Accomplished and notarized Integrated Application Form (in excel and pdf)
- Authorization letter (if applicable)
- Contract manufacturing agreement (if applicable)
- GMP certificates (manufacturer/contract manufacturer)
- Business registration: DTI/SEC/CDA for various ownership types
- ASEAN Common Technical Dossier: 
    - Part I: Administrative data and product info
    - Part II: Quality documents
- Labeling materials
- Risk Management Plan: Generally not required for generic drugs unless requested

### Fees

| **Status** | **Application Fee (5 Years)** | **Brand Name Clearance** | **Annual Fee** | **Legal & Research Fee (LRF)** |
|---|---|---|---|---|
| Unbranded | PHP 10,100 | – | PHP 2,000/year | 1% of application fee |
| Branded | PHP 15,150 | PHP 510/proposed brand name | PHP 3,000/year | 1% of application fee + PHP 30/brand |

Applicant may choose between 2-year or 5-year CPR validity.

### Evaluation Timelines

| **Review Type** | **Timeline (working days)** |
|---|---|
| Preassessment | 5 (subject to completeness of documents) |
| Full Review | up to 120 (response time to deficiencies is excluded) |
| Abridged Review | 45 |
| Verification Review | 30 |
| Renewal | 20 |

### Registration Pathways

- Standard Full Review: For most generics.
- Facilitated Pathways (Abridged, Verification): If product is already approved by a Reference Drug Regulatory Agency (e.g. US FDA, EMA).
- WHO Prequalified, ASEAN Joint Assessment: Special collaborative and reliance reviews where applicable.

### Important Notes / Distinctions

- Separate applications are required for each API, pharmaceutical form, strength, and route of administration.
- Preassessment is mandatory—applications must be complete to proceed.
- Both innovator and generic drugs now use harmonized, streamlined processes; reliance/review on reference agencies’ approvals is increasingly favored for generics but not always applicable.

## Table: Process Overview and Fees

| **Step / Requirement** | **Unbranded Generic** | **Branded Generic** | **Agency Responsible** | **Timeframe (approx.)** |
|---|---|---|---|---|
| License to Operate (prior to CPR) | Required | Required | FDA | – |
| Application (eServices Portal) | Yes | Yes | FDA/CDRR | n/a |
| Dossier (ACTD Format) | Yes | Yes | FDA | n/a |
| GMP Certificate(s) | Yes | Yes | FDA | n/a |
| Application Fee (5yr) + LRF | PHP 10,100+LRF | PHP 15,150+LRF | FDA | – |
| Brand Name Clearance | – | PHP 510/ proposed brand name | FDA | – |
| Evaluation (Standard) | Yes | Yes | FDA (CDRR) | Up to 120 days (excludes deficiency compliance and other related correspondences) |
| Abridged/Verification Pathway (for eligible) | Yes | Yes | FDA (CDRR) | 30–45 days |
| Renewal (before expiry of CPR) | Yes | Yes | FDA | Filing of renewal is still allowed within 90 days before expiry, renewals filed within 120 days from expiry remain valid but will incur surcharge |

### Conclusion

Successfully navigating the generic drug registration Philippines pathway requires accurate documentation, compliance with FDA Philippines requirements, and timely responses to Regulatory queries.

Freyr supports pharmaceutical companies with end-to-end expertise [across the Philippines drug registration process](https://www.freyrsolutions.com/medicinal-products/medicinal-products-regulatory-support-in-philippines) ensuring faster approvals and seamless market entry.